Angiodynamics (ANGO) Other financing activities (2010 - 2026)
Angiodynamics' (ANGO) quarterly Other financing activities came in at $716000.0 in Q1 2026, down 20.0% YoY from $895000.0 in Q1 2025, and up 205.98% on a QoQ basis from $234000.0 in Q3 2025.
Angiodynamics (ANGO) Other financing activities (2010 - 2026) Analysis & Trends
Angiodynamics (ANGO) has 16 years of Other financing activities data on file, last reported at $716000.0 in Q1 2026.
- Quarterly Other financing activities fell 20.0% year-over-year to $716000.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $1.8 million (up 13.4% YoY) and the FY2019 annual result came in at $2.0 million, down 31.13% from the prior year.
- Other financing activities rose to $716000.0 in Q1 2026, from $234000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $941000.0 in Q1 2023 to a low of -$352000.0 in Q4 2023.
- A 5-year average of $346000.0 and a median of $234000.0 in 2025 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2023 — Other financing activities slumped 337.84% — and 2025, when it surged 444.19%.
- Tracing ANGO's Other financing activities over 5 years: stood at $148000.0 in 2022, then tumbled by 337.84% to -$352000.0 in 2023, then jumped by 98.58% to -$5000.0 in 2024, then soared by 4780.0% to $234000.0 in 2025, then surged by 205.98% to $716000.0 in 2026.
- The last three Other financing activities figures came in at $716000.0 (Q1 2026), $234000.0 (Q3 2025), and $895000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.91 Bn | 129.69 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.53 Bn | 51.67 Bn | 2.32 Bn |
| 3 | Alcon | 35.74 Bn | 34.39 Bn | 1.68 Bn |
| 4 | Resmed | 33.94 Bn | 32.47 Bn | 861.22 Mn |
| 5 | Medline | 29.03 Bn | 26.35 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 24.94 Bn | 24.51 Bn | 329.20 Mn |
| 7 | Solventum | 15.29 Bn | 14.89 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.84 Bn | 14.70 Bn | 735.40 Mn |
| 9 | Baxter International | 13.64 Bn | 11.49 Bn | 1.03 Bn |
| 10 | Angiodynamics | 654.45 Mn | 600.59 Mn | 46.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 716,000.00 |
| Feb 28, 2026 | 716,000.00 |
| Aug 31, 2025 | 234,000.00 |
| Aug 31, 2025 | 234,000.00 |
| Feb 28, 2025 | 895,000.00 |
| Feb 28, 2025 | 895,000.00 |
| Nov 30, 2024 | -5,000.00 |
| Nov 30, 2024 | -5,000.00 |
| Aug 31, 2024 | 43,000.00 |
| Aug 31, 2024 | 43,000.00 |
| Feb 29, 2024 | 694,000.00 |
| Feb 29, 2024 | 694,000.00 |
| Nov 30, 2023 | -352,000.00 |
| Nov 30, 2023 | -352,000.00 |
| Aug 31, 2023 | 410,000.00 |
| Aug 31, 2023 | 410,000.00 |
| Feb 28, 2023 | 941,000.00 |
| Feb 28, 2023 | 941,000.00 |
| Nov 30, 2022 | 148,000.00 |
| Nov 30, 2022 | 148,000.00 |